Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Clinical trial NCT03403751 · TERMINATED
Trial details
- NCT number
- NCT03403751
- Sponsor
- Atox Bio Ltd
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-24
- Primary completion
- 2019-12-14
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.